- Home
- APGE vs RDY Comparison
APGE vs RDY Comparison
Compare APGE & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- RDY
- Stock Information
- Founded
- APGE 2022
- RDY 1984
- Country
- APGE United States
- RDY India
- Employees
- APGE N/A
- RDY N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- APGE Health Care
- RDY Health Care
- Exchange
- APGE Nasdaq
- RDY Nasdaq
- Market Cap
- APGE 2.1B
- RDY 2.1B
- IPO Year
- APGE 2023
- RDY N/A
- Fundamental
- Price
- APGE $42.42
- RDY $15.26
- Analyst Decision
- APGE Strong Buy
- RDY Strong Buy
- Analyst Count
- APGE 4
- RDY 2
- Target Price
- APGE $91.33
- RDY $16.95
- AVG Volume (30 Days)
- APGE 791.1K
- RDY 1.7M
- Earning Date
- APGE 08-11-2025
- RDY 07-28-2025
- Dividend Yield
- APGE N/A
- RDY 0.63%
- EPS Growth
- APGE N/A
- RDY 1.47
- EPS
- APGE N/A
- RDY 0.79
- Revenue
- APGE N/A
- RDY $3,809,801,863.00
- Revenue This Year
- APGE N/A
- RDY $10.24
- Revenue Next Year
- APGE $743.14
- RDY N/A
- P/E Ratio
- APGE N/A
- RDY $19.20
- Revenue Growth
- APGE N/A
- RDY 16.61
- 52 Week Low
- APGE $26.20
- RDY $12.26
- 52 Week High
- APGE $63.50
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- APGE 55.77
- RDY 56.86
- Support Level
- APGE $40.48
- RDY $15.16
- Resistance Level
- APGE $44.65
- RDY $16.17
- Average True Range (ATR)
- APGE 2.42
- RDY 0.19
- MACD
- APGE 0.16
- RDY -0.06
- Stochastic Oscillator
- APGE 65.90
- RDY 46.47
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.